Cita APA (7a ed.)

Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, & Qinjie Weng. (2022). Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Elsevier.

Cita Chicago Style (17a ed.)

Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, y Qinjie Weng. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.

Cita MLA (9a ed.)

Jincheng Wang, et al. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.

Precaución: Estas citas no son 100% exactas.